Abstract
PL03.13 Osimertinib With/Without Platinum-Based Chemotherapy as First-line Treatment in Patients with EGFRm Advanced NSCLC (FLAURA2)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
https://doi.org/10.1016/j.jtho.2023.09.009
Journal: Journal of Thoracic Oncology | Publication Date: Oct 31, 2023 |
Citations: 4 |
PL03.13 Osimertinib With/Without Platinum-Based Chemotherapy as First-line Treatment in Patients with EGFRm Advanced NSCLC (FLAURA2)
Join us for a 30 min session where you can share your feedback and ask us any queries you have